Letter: Patient Safety Concerns Remain in House Right to Try Legislation
The American Cancer Society Cancer Action Network together with more than 75 organizations representing millions of patients sent a letter to leadership in the U.S. House of Representatives, expressing concerns about proposed legislation to change the process for accessing experimental drugs without including necessary patient safeguards.